Tonix Pharmaceuticals Holding (TNXP) Return on Sales [ROS] (2023 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted Return on Sales [ROS] of -314.05% for Q2 2026, up 1102.17 percentage points from -1416.22% a year earlier and up 289.86 percentage points from the prior quarter.
Tonix Pharmaceuticals Holding (TNXP) Return on Sales [ROS] (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Tonix Pharmaceuticals Holding was -568.43%, up 269.57 percentage points year-over-year; for FY2025, it was -959.05%, up 395.23 percentage points from FY2024.
- In prior years, Tonix Pharmaceuticals Holding's Return on Sales [ROS] was -1354.28% in FY2024 (+169.66 pp) and -1523.94% in FY2023.
- The Q2 2026 figure stands as the highest quarterly Return on Sales [ROS] in data going back to Q3 2023.
- On a year-over-year basis, Return on Sales [ROS] increased in five of the last eight quarters, with an average year-over-year change of +371.47 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2025, with a gain of 2085.41 percentage points; the weakest was Q3 2025, with a drop of 453.91 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -603.91% (Q1 2026), -895.84% (Q4 2025) and -1005.08% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Tonix Pharmaceuticals Holding | 149.62 Mn | 149.62 Mn | 12.84 Mn | -314.05% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -314.05% |
| Mar 31, 2026 | -603.91% |
| Dec 31, 2025 | -895.84% |
| Sep 30, 2025 | -1,005.08% |
| Jun 30, 2025 | -1,416.22% |
| Mar 31, 2025 | -660.93% |
| Dec 31, 2024 | -870.64% |
| Sep 30, 2024 | -551.17% |
| Jun 30, 2024 | -3,501.63% |
| Mar 31, 2024 | -860.23% |
| Dec 31, 2023 | -723.18% |
| Sep 30, 2023 | -705.62% |
Tonix Pharmaceuticals Holding Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TNXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "TNXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TNXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();